These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Multifactorial immunological treatment of cancer in urology. Reuter HJ Helv Chir Acta; 1976 Jul; 43(3):279-83. PubMed ID: 947866 [No Abstract] [Full Text] [Related]
24. Immunotherapy for Genitourinary Cancers: New Opportunities for Clinical Impact. Nair SS; Tewari AK Urol Clin North Am; 2020 Nov; 47(4):xi-xii. PubMed ID: 33008502 [No Abstract] [Full Text] [Related]
25. Immunotherapy for genitourinary cancer: state of the art and new perspectives. Cattrini C; Dellepiane C; Cavo A; Buzzatti G; Tolomeo F; Messina C; Boccardo F Anticancer Drugs; 2016 Aug; 27(7):585-99. PubMed ID: 27183027 [TBL] [Abstract][Full Text] [Related]
27. Tumor markers in testis tumors. Kansu E Turk J Pediatr; 1984; 26(1-4):277-83. PubMed ID: 6085661 [No Abstract] [Full Text] [Related]
28. The cancer associated antigen test as an index to failure of complete removal of urological cancers. Wechsler M; Lo Gerfo P; Feminella J; Lattimer JK Trans Am Assoc Genitourin Surg; 1972; 64():85-7. PubMed ID: 4347503 [No Abstract] [Full Text] [Related]
29. Monoclonal antibodies in urology: review of reactivities and applications in diagnosis, staging, and therapy. Vessella RL; Chiou RK; Lange PH Semin Urol; 1985 May; 3(2):158-67. PubMed ID: 3916560 [No Abstract] [Full Text] [Related]
30. [Laboratory tests for the diagnosis and follow-up of cancer]. Stenman UH Duodecim; 1986; 102(9):525-33. PubMed ID: 2424709 [No Abstract] [Full Text] [Related]
31. [Tumor diagnosis using tumor-associated antigens]. von Kleist S Dtsch Med Wochenschr; 1980 Nov; 105(45):1557-8. PubMed ID: 6159149 [No Abstract] [Full Text] [Related]
32. [Diagnosis of tumors with the use of immunologic tumor markers]. Vorlaender KO Wien Med Wochenschr; 1983 Feb; 133(3):59-66. PubMed ID: 6189301 [No Abstract] [Full Text] [Related]
33. [Tumors of the male urogenital tract]. Hofstädter F Verh Dtsch Ges Pathol; 1986; 70():172-83. PubMed ID: 2435073 [No Abstract] [Full Text] [Related]
34. [Radioimmunological determination of the carcinoembryonic antigen, alpha-fetoprotein and other tumor antigens in oncological patients before and after radiation therapy]. Dobrovol'skiĭ NM; Matveenko EG; Firsova PP; Gapaniuk ON; Smirnova IA Med Radiol (Mosk); 1979 Oct; 24(10):43-7. PubMed ID: 91939 [No Abstract] [Full Text] [Related]
35. Tumour markers in ovarian cancer. van Nagell JR Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919 [No Abstract] [Full Text] [Related]
36. Immunotargeting and personalized therapies in genitourinary cancers. Mazzucchelli R; Gasparrini S; Galosi AB; Massari F; Ciccarese C; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R Future Oncol; 2016 Aug; 12(16):1853-6. PubMed ID: 27113700 [No Abstract] [Full Text] [Related]
38. The role of tumor markers in the diagnosis and management of gastrointestinal cancer. Heptner G; Domschke S; Domschke W Hepatogastroenterology; 1986 Aug; 33(4):140-4. PubMed ID: 2428718 [No Abstract] [Full Text] [Related]